Table 1. Patients' clinical and demographic characteristics. Data are presented as mean±SD or absolute values.
| Glomerulopathy patients (n = 99) | |
| Age (years) | 36±11 |
| Gender (M/F) | 46/53 |
| Renal biopsy diagnosis | |
| FSGS | 49 |
| MN | 29 |
| IgAN | 9 |
| MPGN | 8 |
| ML | 4 |
| Disease duration (months) | 33.6±26.0 |
| Arterial Hypertension | 40 |
| Diabetes | 6 |
| Familial nephropathy history | 21 |
| Presence of edema | 31 |
| Mean eGFR (mL/min/1.73 m2) | 61±29 |
| CKD stage | |
| stage 1 | 55 |
| stage 2 | 24 |
| stage 3 | 16 |
| stage 4 | 04 |
| ACE inhibitor/AT1R blocker | 62 |
| Steroid therapy | 43 |
| Cyclosporine therapy | 19 |
| Cyclophosphamide therapy | 03 |
| Hemoglobin (g/dL) | 12.3±0.9 |
| Last serum albumin (g/dL) | 3.6±0.9 |
| Last total cholesterol (mg/dL) | 221±98 |
| Last triglycerides (mg/dL) | 146±58 |
| Proteinuria at diagnosis (g/24 h/1.73 m2) | 8.6±3.8 |
| Last proteinuria (g/24 h/1.73 m2) | 2.8±2.2 |
| Remission | |
| Total | 38 |
| Parcial | 26 |
| No | 35 |
FSGS: focal and segmentar glomerulosclerosis; ML: minimal lesions; MN: membranous Nephropathy; IgAN: IgA nephropathy; MPGN: membranoproliferative Glomerulonephritis; CKD: Chronic Kidney Disease; ACE: angiotensin converting enzyme; AT1R: angiotensin 1 receptor.